Key Points The Consumer Price Index (CPI) rose 2.7% annually in November, below estimates at 3.1%. Investors cheered the news as it could encourage the Fed to lower rates. Retailers are seeing consumers trade down to cheaper products. 10 stocks we like better than S&P 500 Index › Two days after investors received an employment report that showed the labor market continuing to wobble, investors got a key economic report with better news. Inflation, as measured by the Consumer Price Index (CPI), ...

Activity at factories in the central U.S. eked out growth in December, cooling from last month's activity as production and labor-market measures dragged. ...

Key Takeaways CLSK's valuation looks stretched as its forward P/E of 50.83X far exceeds the industry average.CleanSpark's revenues and earnings remain tightly linked to Bitcoin prices, amplifying volatility risk.AI and HPC expansion is still unproven for CLSK amid rising competition and declining earnings estimates.CleanSpark, Inc. (CLSK) is a leading U.S. Bitcoin miner and data-center operator that is expanding beyond crypto mining into high-performance computing (HPC) and artificial intelligence (AI) infr ...

Key Takeaways CME gains from market volatility, with clearing and transaction fees remaining its largest revenue driver. CME is seeing higher crypto trading activity, aided by growing participation in the crypto economy. CME's strong cash flow supports dividends, and investments in data, products, and clearing services. Shares of CME Group Inc. (CME) have gained 15.5% in the past year, outperforming the industry's growth of 8.1%. CME Group has outperformed its peers, including Intercontinental Exchange Inc. ...

Key Takeaways J&J's oncology sales rose 20.6% to $18.52B, fueled by Darzalex, Erleada and new cancer drugs.ImmunityBio's Anktiva gained U.S. approval for NMIBC, with $74.7M in 2025 sales.Foghorn Therapeutics is advancing FHD-909 for SMARCA4-mutant cancers.An updated edition of the October 28, 2025, article.The global oncology market is entering a period of significant evolution, supported by rising cancer incidence and rapid scientific advancement. The American Cancer Society estimates that the United State ...

*Real-time prices by Nasdaq Last Sale. Real-time quote and/or trade prices are not sourced from all markets. Ownership data provided by LSEG and Estimate data provided by FactSet. IBD, IBD Digital, IBD Live, IBD Weekly, Investor's Business Daily, Leaderboard, MarketDiem, MarketSurge and other marks are trademarks owned by Investor's Business Daily, LLC. ©2025 Investor's Business Daily, LLC. All Rights Reserved. About Us Reviews Site Map Your Ad Choices Advertising Contact us IBD Stock Charts IBD Stock Check ...

(Bloomberg) -- UBS Group AG is set to begin its latest wave of job cuts in mid-January, according to people familiar with the matter. That step will be followed by another round later in 2026 as UBS intends to switch off computer systems it acquired when it took over its former competitor in 2023, the people said, asking not to be named discussing internal matters.UBS is entering the final year of its historic integration of Credit Suisse, which it bought in an emergency government-brokered deal in 2023. Th ...

You can find original article here WealthManagement. Subscribe to our free daily WealthManagement newsletters. (Bloomberg) -- UBS Group AG is set to begin its latest wave of job cuts in mid-January, according to people familiar with the matter.  That step will be followed by another round later in 2026 as UBS intends to switch off computer systems it acquired when it took over its former competitor in 2023, the people said, asking not to be named discussing internal matters. UBS is entering the fi ...

Core Insights - Micron's stock surged significantly following a strong earnings report, driven by tighter supply in the memory market [1] - The company’s advanced memory production for AI is sold out through 2026, with memory pricing increasing by 20% quarter-over-quarter and storage chips rising in the mid-teens [2] - Micron's CFO anticipates continued improvement in margins and performance through fiscal 2026, although pricing increases are expected to slow after February [2] Industry Impact - The rising memory costs are affecting major hyperscalers like Amazon, Microsoft, and Google, which need these chips for AI data centers, leading to higher operational costs [4] - Server manufacturers such as Dell, Lenovo, and HPE are passing on increased costs to consumers, with HPE raising server prices by 15% and Dell expected to increase prices by 15-20% [4][5] - Broadcom is also experiencing margin compression due to rising memory costs, contributing to an 11% decline in their stock post-earnings [5]

If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare industries, and understanding the key trends and catalysts driving valuations ahead of the market, why not subscribe to my weekly newsletter via my Investing Group, Haggerston BioHealth ?When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. ( RXRX ) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4.5Edmund Ing ...